Affimed NV (NASDAQ:AFMD)
| 0.47 Delayed Data As of 3:59pm ET |  -0.02 / -4.08%Today’s Change | 0.45 Today|||52-Week Range 2.55 | -62.10% Year-to-Date |
Latest AFMD News | Press Releases
No recent news for Affimed NV.
Today’s Trading
| Previous close | 0.49 |
| Today’s open | 0.51 |
| Day’s range | 0.47 - 0.52 |
| Volume | 26,982 |
| Average volume (3 months) | 884,839 |
| Market cap | $68.5M |
Data as of 3:59pm ET, 09/29/2023
Growth & Valuation
| Earnings growth (last year) | -11.60% |
| Earnings growth (this year) | -26.39% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -8.91% |
| P/E ratio | NM |
| Price/Sales | 4.06 |
| Price/Book | 0.42 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| OCUPOcuphire Pharma Inc | -0.14 | -4.02% |
| EYENEyenovia Inc | -0.05 | -2.91% |
| ---- | ||
| PRPHProphase Labs Inc | +0.08 | +1.83% |
Data as of 4:00pm ET, 09/29/2023
Financials
| Next reporting date | November 8, 2023 |
| EPS forecast (this quarter) | -$0.18 |
| Annual revenue (last year) | $43.5M |
| Annual profit (last year) | -$90.4M |
| Net profit margin | -207.98% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Heidelberg, Baden Wuerttemberg |
Forecasts
